Cargando…

Representing antibiotic relationships using measurements of efficacy against clinical isolates

Introduction. Antimicrobial resistance (AMR) is a worrying and confusing problem for both patients and medical professionals. It is often difficult for non-specialists to understand how different antibiotics are related to one another. Here, I use experimental data from hundreds of thousands of clin...

Descripción completa

Detalles Bibliográficos
Autor principal: Shaw, Liam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520714/
https://www.ncbi.nlm.nih.gov/pubmed/32995554
http://dx.doi.org/10.12688/wellcomeopenres.15304.3
_version_ 1783587831970529280
author Shaw, Liam
author_facet Shaw, Liam
author_sort Shaw, Liam
collection PubMed
description Introduction. Antimicrobial resistance (AMR) is a worrying and confusing problem for both patients and medical professionals. It is often difficult for non-specialists to understand how different antibiotics are related to one another. Here, I use experimental data from hundreds of thousands of clinical isolates to infer relationships between antibiotics and represent them with simple diagrams. Methods. The minimum inhibitory concentration (MIC) of a bacterial isolate for a given antibiotic is defined as the lowest concentration that prevents visible growth. Measuring MICs for multiple antibiotics using the same isolate implicitly records the relationships of the antibiotics for a given species. The basic principle is that antibiotics with similar mechanisms of action should give rise to similar mechanisms of resistance, so should have correlated MICs across large numbers of isolates. This information can then be used to calculate distances between antibiotics based on pairwise correlations of their rank-ordered MICs. I apply this approach to a large historical AMR surveillance dataset (the Pfizer ATLAS surveillance dataset, 2004-2017). Results. I demonstrate that clustering antibiotics in this way allows a simple visual comparison of how similar antibiotics are to each other based on their efficacy within a species. The resulting visualizations broadly recapitulate antibiotic classes. They also clearly show the dramatic effects of combining beta-lactam antibiotics with beta-lactamase inhibitors, as well as highlighting antibiotics which have unexpected correlations in MICs that are not predicted from their chemical similarities alone. Conclusion. Large AMR surveillance datasets can be used in a hypothesis-free manner to show relationships between antibiotics based on their real-world efficacy.
format Online
Article
Text
id pubmed-7520714
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-75207142020-09-28 Representing antibiotic relationships using measurements of efficacy against clinical isolates Shaw, Liam Wellcome Open Res Research Article Introduction. Antimicrobial resistance (AMR) is a worrying and confusing problem for both patients and medical professionals. It is often difficult for non-specialists to understand how different antibiotics are related to one another. Here, I use experimental data from hundreds of thousands of clinical isolates to infer relationships between antibiotics and represent them with simple diagrams. Methods. The minimum inhibitory concentration (MIC) of a bacterial isolate for a given antibiotic is defined as the lowest concentration that prevents visible growth. Measuring MICs for multiple antibiotics using the same isolate implicitly records the relationships of the antibiotics for a given species. The basic principle is that antibiotics with similar mechanisms of action should give rise to similar mechanisms of resistance, so should have correlated MICs across large numbers of isolates. This information can then be used to calculate distances between antibiotics based on pairwise correlations of their rank-ordered MICs. I apply this approach to a large historical AMR surveillance dataset (the Pfizer ATLAS surveillance dataset, 2004-2017). Results. I demonstrate that clustering antibiotics in this way allows a simple visual comparison of how similar antibiotics are to each other based on their efficacy within a species. The resulting visualizations broadly recapitulate antibiotic classes. They also clearly show the dramatic effects of combining beta-lactam antibiotics with beta-lactamase inhibitors, as well as highlighting antibiotics which have unexpected correlations in MICs that are not predicted from their chemical similarities alone. Conclusion. Large AMR surveillance datasets can be used in a hypothesis-free manner to show relationships between antibiotics based on their real-world efficacy. F1000 Research Limited 2020-09-17 /pmc/articles/PMC7520714/ /pubmed/32995554 http://dx.doi.org/10.12688/wellcomeopenres.15304.3 Text en Copyright: © 2020 Shaw L http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shaw, Liam
Representing antibiotic relationships using measurements of efficacy against clinical isolates
title Representing antibiotic relationships using measurements of efficacy against clinical isolates
title_full Representing antibiotic relationships using measurements of efficacy against clinical isolates
title_fullStr Representing antibiotic relationships using measurements of efficacy against clinical isolates
title_full_unstemmed Representing antibiotic relationships using measurements of efficacy against clinical isolates
title_short Representing antibiotic relationships using measurements of efficacy against clinical isolates
title_sort representing antibiotic relationships using measurements of efficacy against clinical isolates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520714/
https://www.ncbi.nlm.nih.gov/pubmed/32995554
http://dx.doi.org/10.12688/wellcomeopenres.15304.3
work_keys_str_mv AT shawliam representingantibioticrelationshipsusingmeasurementsofefficacyagainstclinicalisolates